Severe hypocalcemia - a problem of an early postoperative period after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients

Aim: to investigate the risk factors for severe hypocalcemia (SH) after parathyroidectomy (PTx) in dialysis-treated CKD stage 5D patients with secondary hyperparathyroidism. Materials and methods: we performed a retrospective cohort study included 318 severe SHPT dialysis-dependent patients who underwent successful subtotal or total PTx with autotransplantation of parathyroid tissue. Severe postoperative hypocalcemia was defined as an ionized serum calcium level less than 0.9 mmol/l on a day 2 after surgery. Results:The incidence of early postoperative SH in our cohort was 66% (210 from 318). Univariate analysis showed that SH patients in comparison with non-SH group were significantly younger (44 [37; 54] vs 52 [43; 59] years, р<0.0001), had higher baseline PTH (134 [99.6; 185] vs 89 [67.5; 114] pmol/l, р<0.0001) and alkaline phosphatase (AP) levels (380.6 [191; 681] vs 130 [96; 175] IU/l, р<0.0001), lower baseline serum total calcium (Ca) level (2.46±0.22 vs 2.57±0.21 mmol/l, р<0.0001) and ionized Ca (1.2 [1.11; 1.28] vs 1.28 [1.21; 1.36] mmol/l, р<0.0001), higher ΔPTH before/after surgery (126 [90.6; 175] vs 81.1 [60; 105.1], р<0.0001). The multivariate logistic regression revealed AP level as the only independent risk factor of severe hypocalcemia development after PTx (OR 3.8 [1.7; 8.2] per each 100 IU/l, р=0.001). Sex, dialysis vintage, RRT modality (hemodialysis or peritoneal dialysis) and type of surgery were not associated with risk of SH (р=0.55, 0.21, 0.27 and 0.81, respectively). In nested models excluding AP significant factors of postoperative SH were preoperative PTH (OR 1.03 [1.02; 1.032] per each pmol/l, р<0.001), ΔPTH before/after surgery (OR 1.03 [1.02; 1.034] per each pmol/l, р<0.001), age (OR 0.96 [0.94; 0.99] per a year, р=0.003), baseline total serum Ca (OR 0.2 [0.05; 0.78] per each mmol/l, р=0.021). The length of hospital stay was significantly longer in SH patients (р=0.0016). Conclusions: the preoperative AP level was the most important predictor of the development of severe postoperative hypocalcemia in patients after PTx due to secondary hyperparathyroidism. In addition, important risk factors may include young age, low baseline total calcium levels, high PTH levels before surgery.

гипокальциемия, синдром «голодной кости», диализ, вторичный гиперпаратиреоз, паратиреоидэктомия, паратиреоидный гормон, кальций, щелочная фосфатаза, hypocalcemia, hungry bone syndrome, dialysis, secondary hyperparathyroidism, parathyroidectomy, parathyroid hormone, calcium, alkaline phosphatase

1. Kim S., Long J., Montez-Rath M. et al. Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States. Clinical Journal of the American Society of Nephrology. 2016;11(7):1260-1267. doi:10.2215/cjn.10370915

2. Lau W., Obi Y., Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2018;13(6):952-961. doi: 10.2215/CJN.10390917

3. Nephro.ru [Интернет]. Профессиональная организация: Общественная общероссийская организация «Российское диализное общество». Национальные клинические рекомендации: минеральные и костные нарушения при хронической болезни почек. 2015. Доступно по ссылке: http://www.nephro.ru/content/files/recomendations/ckdmbdNationalGuidelines.pdf.

4. Ho L., Wong P., Sin H. et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism. BMC Nephrol. 2017;18(1). doi:10.1186/s12882-016-0421-5

5. Kritmetapak K., Kongpetch S., Chotmongkol W. et al. Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism. Ren Fail. 2020;42(1):1118-1126. doi:10.1080/0886022x.2020.1841655

6. Yang M., Zhang L., Huang L. et al. Factors predictive of critical value of hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. Ren Fail. 2016;38(8):1224-1227. doi:10.1080/0886022x.2016.1202731

7. Tsai W., Peng Y., Chiu Y. et al. Risk factors for severe hypocalcemia after parathyroidectomy in prevalent dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2015;47(7):1203-1207. doi:10.1007/s11255-015-1016-y

8. Yang G., Ge Y., Zha X. et al. Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019;51(3):535-542. doi:10.1007/s11255-019-02076-7

9. Ko W., Liu C., Lee J. Osteocalcin is an independent predictor for hungry bone syndrome after parathyroidectomy. World J Surg. 2019;44(3):795-802. doi:10.1007/s00268-019-05251-0

10. Sun X., Zhang X., Lu Y. Risk factors for severe hypocalcemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-26142-9

11. Wang M., Chen B., Zou X. et al. A nomogram to predict hungry bone syndrome after parathyroidectomy in patients with secondary hyperparathyroidism. Journal of Surgical Research. 2020;255:33-41. doi:10.1016/j.jss.2020.05.036

12. Yang G., Zha X., Mao H. et al. Hypocalcemia-based prediction of hungry bone syndrome after parathyroidectomy in hemodialysis patients with refractory secondary hyperparathyroidism. Journal of International Medical Research. 2018;46(12):4985-4994. doi:10.1177/0300060518788744

13. Liu J., Huang Q., Yang M. et al. Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism. Journal of International Medical Research. 2020;48(1):030006051989750. doi:10.1177/0300060519897505

14. Ge Y., Yang G., Wang N. et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. Int Urol Nephrol. 2019;51(8):1443-1449. doi:10.1007/s11255-019-02217-y

15. Torer N., Torun D., Torer N. et al. Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. Transplant Proc. 2009;41(9):3642-3646. doi:10.1016/j.transproceed.2009.06.207

16. Evenepoel P., Cunningham J., Ferrari S. et al. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D. Nephrology Dialysis Transplantation. 2020;36(1):42-59. doi:10.1093/ndt/gfaa192

17. Wong J., Fu W., Lim E. et al. Hungry bone syndrome after parathyroidectomy in end-stage renal disease patients: review of an alkaline phosphatase-based treatment protocol. Int Urol Nephrol. 2020;52(3):557-564. doi:10.1007/s11255-020-02387-0

18. Ketteler M., Block G., Evenepoel P. et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters. Kidney Int. 2017;92(1):26-36. doi:10.1016/j.kint.2017.04.006

19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-130. doi: 10.1038/ki.2009.188